EZZ Life Science Holdings Ltd. (AU:EZZ) recently announced an update regarding the issuance of new shares to a sophisticated investor. The Australian genomic life science company revealed that they have issued 1,708,200 new shares to the investor at $0.50 each under section 708A(5)(e) of the Corporations Act. This issuance was done without the need for disclosure to investors, as allowed by the provision.
EZZ Life Science Holdings Ltd. is known for its focus on addressing significant health challenges and has a strong e-commerce presence. The company has confirmed that it has complied with all necessary legal provisions in regards to the share issuance, with no excluded information required to be disclosed in this particular notice.
Those interested in further insights into AU:EZZ stock can check out TipRanks’ Stock Analysis page, which provides valuable information on EZZ Life Science Holdings Ltd.’s latest developments and activities in the genomic life science sector. With this recent update, investors can stay informed on the company’s progress and potential future prospects in the industry.
